158 related articles for article (PubMed ID: 7820575)
1. Vascular and metabolic factors in the pathogenesis of experimental diabetic neuropathy in mature rats.
Wright RA; Nukada H
Brain; 1994 Dec; 117 ( Pt 6)():1395-407. PubMed ID: 7820575
[TBL] [Abstract][Full Text] [Related]
2. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
[TBL] [Abstract][Full Text] [Related]
3. Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy.
Kishi Y; Schmelzer JD; Yao JK; Zollman PJ; Nickander KK; Tritschler HJ; Low PA
Diabetes; 1999 Oct; 48(10):2045-51. PubMed ID: 10512372
[TBL] [Abstract][Full Text] [Related]
4. Are disturbances of sorbitol, phosphoinositide, and Na+-K+-ATPase regulation involved in pathogenesis of diabetic neuropathy?
Greene DA; Lattimer SA; Sima AA
Diabetes; 1988 Jun; 37(6):688-93. PubMed ID: 2838351
[TBL] [Abstract][Full Text] [Related]
5. [Alterations in the sorbitol pathway and Na(+)-K(+)-ATPase activity of peripheral nerve of alloxan-induced diabetic rats].
Lu KM; Zhong XL; Zhu XX; Zhu QY
Sheng Li Xue Bao; 1990 Aug; 42(4):401-5. PubMed ID: 2175949
[TBL] [Abstract][Full Text] [Related]
6. Effect of a potent new aldose reductase inhibitor, (5-(3-thienyltetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats.
Hotta N; Kakuta H; Fukasawa H; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K
Diabetes Res Clin Pract; 1995 Feb; 27(2):107-17. PubMed ID: 7607048
[TBL] [Abstract][Full Text] [Related]
7. A sodium-pump defect in diabetic peripheral nerve corrected by sorbinil administration: relationship to myo-inositol metabolism and nerve conduction slowing.
Greene DA
Metabolism; 1986 Apr; 35(4 Suppl 1):60-5. PubMed ID: 2421135
[TBL] [Abstract][Full Text] [Related]
8. Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration.
Pop-Busui R; Marinescu V; Van Huysen C; Li F; Sullivan K; Greene DA; Larkin D; Stevens MJ
Diabetes; 2002 Aug; 51(8):2619-28. PubMed ID: 12145179
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of diabetic neuropathy: role of altered phosphoinositide metabolism.
Greene DA; Lattimer-Greene S; Sima AA
Crit Rev Neurobiol; 1989; 5(2):143-219. PubMed ID: 2561904
[TBL] [Abstract][Full Text] [Related]
10. Supplemental myo-inositol prevents L-fucose-induced diabetic neuropathy.
Sima AA; Dunlap JA; Davidson EP; Wiese TJ; Lightle RL; Greene DA; Yorek MA
Diabetes; 1997 Feb; 46(2):301-6. PubMed ID: 9000708
[TBL] [Abstract][Full Text] [Related]
11. Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve.
Coppey LJ; Davidson EP; Dunlap JA; Lund DD; Yorek MA
Int J Exp Diabetes Res; 2000; 1(2):131-43. PubMed ID: 11469397
[TBL] [Abstract][Full Text] [Related]
12. Prevention of some electrophysiologic and biochemical abnormalities with oxygen supplementation in experimental diabetic neuropathy.
Low PA; Tuck RR; Dyck PJ; Schmelzer JD; Yao JK
Proc Natl Acad Sci U S A; 1984 Nov; 81(21):6894-8. PubMed ID: 6593734
[TBL] [Abstract][Full Text] [Related]
13. Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy.
Stevens MJ; Obrosova I; Cao X; Van Huysen C; Greene DA
Diabetes; 2000 Jun; 49(6):1006-15. PubMed ID: 10866054
[TBL] [Abstract][Full Text] [Related]
14. Sorbitol, myo-inositol and sodium-potassium ATPase in diabetic peripheral nerve.
Greene DA
Drugs; 1986; 32 Suppl 2():6-14. PubMed ID: 3024950
[TBL] [Abstract][Full Text] [Related]
15. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy.
Dyck PJ; Zimmerman BR; Vilen TH; Minnerath SR; Karnes JL; Yao JK; Poduslo JF
N Engl J Med; 1988 Sep; 319(9):542-8. PubMed ID: 3136330
[TBL] [Abstract][Full Text] [Related]
16. Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Salvemini D; Yorek MA
Br J Pharmacol; 2001 Sep; 134(1):21-9. PubMed ID: 11522593
[TBL] [Abstract][Full Text] [Related]
17. Neural dysfunction and metabolic imbalances in diabetic rats. Prevention by acetyl-L-carnitine.
Ido Y; McHowat J; Chang KC; Arrigoni-Martelli E; Orfalian Z; Kilo C; Corr PB; Williamson JR
Diabetes; 1994 Dec; 43(12):1469-77. PubMed ID: 7958501
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of nerve Na(+)-K(+)-ATPase activity independently of myo-inositol level by PGE1 analogue OP-1206.alpha-CD in streptozocin-induced diabetic rats.
Sonobe M; Yasuda H; Hisanaga T; Maeda K; Yamashita M; Kawabata T; Kikkawa R; Taniguchi Y; Shigeta Y
Diabetes; 1991 Jun; 40(6):726-30. PubMed ID: 1645681
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
Cameron NE; Cotter MA; Basso M; Hohman TC
Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
[TBL] [Abstract][Full Text] [Related]
20. Altered sorbitol and myo-inositol metabolism as the basis for defective protein kinase C and (Na,K)-ATPase regulation in diabetic neuropathy.
Greene DA; Lattimer SA
Ann N Y Acad Sci; 1986; 488():334-40. PubMed ID: 3034118
[No Abstract] [Full Text] [Related]
[Next] [New Search]
